Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 5, 2006, Pages 1353-1360

  Hershman, Dawn L ^a,b,c   Wang, Xiaoyan ^b   McBride, Russell ^b   Jacobson, Judith S ^b   Grann, Victor R ^a,b,c   Neugut, Alfred I ^a,b,c  

^a College of Physicians and Surgeons ^*  (United States)

^b Columbia University ^*  (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Breast cancer; Delay; Radiotherapy; Survival

Indexed keywords

BREAST CANCER; LINEAR REGRESSION; LUMPECTOMY; MORTALITY;

CHEMOTHERAPY; COMPUTER SIMULATION; HEALTH RISKS; RADIOTHERAPY; REGRESSION ANALYSIS; SURGERY; TUMORS;

ONCOLOGY;

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHRONOTHERAPY; COMORBIDITY; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY INTERVENTION; EPIDEMIOLOGICAL DATA; FEMALE; GROUPS BY AGE; HAZARD ASSESSMENT; HEALTH SURVEY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MARRIAGE; MEDICARE; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; RISK FACTOR; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME; BREAST TUMOR; MORTALITY; SEGMENTAL MASTECTOMY; SURVIVAL; TIME;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33748563962     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.03.048     Document Type: Article

References (47)

1. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer. An overview of the randomised trials. Lancet 352 9132 (1998) 930-942
2. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. An overview of the randomised trials. Lancet 351 (1998) 1451-1467
3. Whelan T.J., Julian J., Wright J., Jadad A.R., and Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
4. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer. An overview of the randomised trials. Lancet 355 (2000) 1757-1770
5. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy. Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
6. Coburn N.G., Chung M.A., Fulton J., and Cady B. Decreased breast cancer tumor size, stage, and mortality in Rhode Island. An example of a well-screened population. Cancer Control 11 (2004) 222-230
7. Caplan L.S., Helzlsouer K.J., Shapiro S., Freedman L.S., Coates R.J., and Edwards B.K. System delay in breast cancer in whites and blacks. Am J Epidemiol 142 (1995) 804-812
8. Caplan L.S., Wells B.L., and Haynes S. Breast cancer screening among older racial/ethnic minorities and whites. Barriers to early detection. J Gerontol 47 Spec. No. (1992) 101-110
9. Bickell N.A., and Young G.J. Coordination of care for early-stage breast cancer patients. J Gen Intern Med 16 (2001) 737-742
10. Freeman H.P., Muth B.J., and Kerner J.F. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 3 (1995) 19-30
11. Richards M.A., Westcombe A.M., Love S.B., Littlejohns P., and Ramirez A.J. Influence of delay on survival in patients with breast cancer. A systematic review. Lancet 353 (1999) 1119-1126
12. Huang J., Barbera L., Brouwers M., Browman G., and Mackillop W.J. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21 (2003) 555-563
13. Hebert-Croteau N., Freeman C.R., Latreille J., and Brisson J. Delay in adjuvant radiation treatment and outcomes of breast cancer-a review. Breast Cancer Res Treat 74 (2002) 77-94
14. Hebert-Croteau N., Freeman C.R., Latreille J., Rivard M., and Brisson J. A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat 88 (2004) 187-196
15. Vujovic O., Perera F., Dar A.R., et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?. Int J Radiat Oncol Biol Phys 40 (1998) 869-874
16. Warren J.L., Harlan L.C., Fahey A., et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40 8 Suppl (2002) IV-55-61
17. Warren J.L., Klabunde C.N., Schrag D., Bach P.B., and Riley G.F. Overview of the SEER-Medicare data. Content, research applications, and generalizability to the United States elderly population. Med Care 40 8 Suppl (2002) IV-3-18
18. Du X.L., Osborne C., and Goodwin J.S. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 20 (2002) 4636-4642
19. Du X., Freeman J.L., and Goodwin J.S. Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol 52 (1999) 463-470
20. Charlson M.E., Sax F.L., MacKenzie C.R., Fields S.D., Braham R.L., and Douglas Jr. R.G. Assessing illness severity. Does clinical judgment work?. J Chronic Dis 39 (1986) 439-452
21. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
22. Klabunde C.N., Potosky A.L., Legler J.M., and Warren J.L. Development of a comorbidity index using physician claims data. J Clin Epidemiol 53 (2000) 1258-1267
23. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265 (1991) 391-395
24. Buzdar A.U., Kau S.W., Smith T.L., et al. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer 71 (1993) 3680-3684
25. Recht A., Come S.E., Gelman R.S., et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer. Sequencing, timing, and outcome. J Clin Oncol 9 (1991) 1662-1667
26. Clarke D.H., Le M.G., Sarrazin D., et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy. Experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11 (1985) 137-145
27. Nixon A.J., Recht A., Neuberg D., et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys 30 (1994) 17-21
28. Froud P.J., Mates D., Jackson J.S., et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 46 (2000) 363-372
29. Caplan L.S., Helzlsouer K.J., Shapiro S., Wesley M.N., and Edwards B.K. Reasons for delay in breast cancer diagnosis. Prev Med 25 (1996) 218-224
30. Gwyn K., Bondy M.L., Cohen D.S., et al. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100 (2004) 1595-1604
31. Shavers V.L., Harlan L.C., and Stevens J.L. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97 (2003) 134-147
32. Ghafoor A., Jemal A., Ward E., Cokkinides V., Smith R., and Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53 (2003) 342-355
33. Albain U., Green, Hutchins, Rivkin, Martino, Livingston, and Osborne. Outcome of African Americans on the Southwest Oncology Group (SWOG) breast cancer adjuvant therapy trials [Abstract]. Breast Cancer Res Treat 82 Suppl (2003) 21
34. Schroen A.T., Brenin D.R., Kelly M.D., Knaus W.A., and Slingluff Jr. C.L. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 23 (2005) 7074-7080
35. Haggstrom D.A., Quale C., and Smith-Bindman R. Differences in the quality of breast cancer care among vulnerable populations. Cancer 104 (2005) 2347-2358
36. Hatzell T.A., Ricketts T.C., Tropman S.E., Paskett E.D., and Cooper M.R. Rural physicians' understanding of the state-of-the-art in breast, colon and rectum cancer treatment. Cancer Causes Control 10 (1999) 261-267
37. Tropman S.E., Ricketts T.C., Paskett E., Hatzell T.A., Cooper M.R., and Aldrich T. Rural breast cancer treatment. Evidence from the Reaching Communities for Cancer Care (REACH) project. Breast Cancer Res Treat 56 (1999) 59-66
38. Murri R., Ammassari A., Trotta M.P., et al. Patient-reported and physician-estimated adherence to HAART. Social and clinic center-related factors are associated with discordance. J Gen Intern Med 19 (2004) 1104-1110
39. Jackevicius C.A., Mamdani M., and Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288 (2002) 462-467
40. Waeber B., Leonetti G., Kolloch R., and McInnes G.T. Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. J Hypertens 17 (1999) 1041-1045
41. Misdrahi D., Llorca P.M., Lancon C., and Bayle F.J. [Compliance in schizophrenia: Predictive factors, therapeutical considerations and research implications]. Encephale 28 3 Pt 1 (2002) 266-272
42. McDonnell P.J., and Jacobs M.R. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36 (2002) 1331-1336
43. Horwitz R.I., and Horwitz S.M. Adherence to treatment and health outcomes. Arch Intern Med 153 (1993) 1863-1868
44. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 303 (1980) 1038-1041
45. Wood W.C., Budman D.R., Korzun A.H., et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 330 (1994) 1253-1259
46. Hryniuk W. Re. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. J Natl Cancer Inst 91 (1999) 1425
47. Budman D.R., Berry D.A., Cirrincione C.T., et al., The Cancer and Leukemia Group B. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. J Natl Cancer Inst 90 (1998) 1205-1211